Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 181.17
MED's Cash to Debt is ranked higher than
77% of the 901 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.91 vs. MED: 181.17 )
Ranked among companies with meaningful Cash to Debt only.
MED' s 10-Year Cash to Debt Range
Min: 0.06  Med: 1.70 Max: N/A
Current: 181.17
Equity to Asset 0.75
MED's Equity to Asset is ranked higher than
89% of the 846 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.47 vs. MED: 0.75 )
Ranked among companies with meaningful Equity to Asset only.
MED' s 10-Year Equity to Asset Range
Min: 0.26  Med: 0.73 Max: 0.8
Current: 0.75
0.26
0.8
F-Score: 7
Z-Score: 11.71
M-Score: -3.09
WACC vs ROIC
5.62%
72.83%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 11.13
MED's Operating margin (%) is ranked higher than
82% of the 901 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.60 vs. MED: 11.13 )
Ranked among companies with meaningful Operating margin (%) only.
MED' s 10-Year Operating margin (%) Range
Min: -44.4  Med: 10.15 Max: 14.83
Current: 11.13
-44.4
14.83
Net-margin (%) 4.63
MED's Net-margin (%) is ranked higher than
68% of the 901 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.39 vs. MED: 4.63 )
Ranked among companies with meaningful Net-margin (%) only.
MED' s 10-Year Net-margin (%) Range
Min: -68.63  Med: 6.39 Max: 33.43
Current: 4.63
-68.63
33.43
ROE (%) 14.05
MED's ROE (%) is ranked higher than
71% of the 885 Companies
in the Global Specialty Retail industry.

( Industry Median: 7.72 vs. MED: 14.05 )
Ranked among companies with meaningful ROE (%) only.
MED' s 10-Year ROE (%) Range
Min: -335.37  Med: 19.85 Max: 214.24
Current: 14.05
-335.37
214.24
ROA (%) 10.18
MED's ROA (%) is ranked higher than
83% of the 906 Companies
in the Global Specialty Retail industry.

( Industry Median: 3.25 vs. MED: 10.18 )
Ranked among companies with meaningful ROA (%) only.
MED' s 10-Year ROA (%) Range
Min: -51.27  Med: 13.80 Max: 49.76
Current: 10.18
-51.27
49.76
ROC (Joel Greenblatt) (%) 84.86
MED's ROC (Joel Greenblatt) (%) is ranked higher than
90% of the 903 Companies
in the Global Specialty Retail industry.

( Industry Median: 14.07 vs. MED: 84.86 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
MED' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -130.05  Med: 41.00 Max: 102.5
Current: 84.86
-130.05
102.5
Revenue Growth (3Y)(%) 2.10
MED's Revenue Growth (3Y)(%) is ranked lower than
53% of the 724 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.80 vs. MED: 2.10 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
MED' s 10-Year Revenue Growth (3Y)(%) Range
Min: -45.9  Med: 30.85 Max: 63.6
Current: 2.1
-45.9
63.6
EBITDA Growth (3Y)(%) 6.00
MED's EBITDA Growth (3Y)(%) is ranked higher than
61% of the 608 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.20 vs. MED: 6.00 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
MED' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 6  Med: 25.25 Max: 78.8
Current: 6
6
78.8
EPS Growth (3Y)(%) 8.00
MED's EPS Growth (3Y)(%) is ranked higher than
64% of the 549 Companies
in the Global Specialty Retail industry.

( Industry Median: -0.30 vs. MED: 8.00 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
MED' s 10-Year EPS Growth (3Y)(%) Range
Min: -12.1  Med: 23.95 Max: 68.9
Current: 8
-12.1
68.9
» MED's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2014

MED Guru Trades in Q3 2014

Jim Simons 236,200 sh (+43.15%)
John Burbank 6,170 sh (-17.80%)
Richard Snow 39,500 sh (-26.72%)
Chuck Royce 800 sh (-98.67%)
» More
Q4 2014

MED Guru Trades in Q4 2014

Chuck Royce 2,200 sh (+175.00%)
Jim Simons 307,800 sh (+30.31%)
John Burbank Sold Out
Richard Snow Sold Out
» More
Q1 2015

MED Guru Trades in Q1 2015

James Barrow 83,022 sh (New)
Jim Simons 380,100 sh (+23.49%)
Chuck Royce 1,400 sh (-36.36%)
» More
Q2 2015

MED Guru Trades in Q2 2015

Jim Simons 544,925 sh (+43.36%)
James Barrow 87,767 sh (+5.72%)
Chuck Royce 1,400 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with MED

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 28.38
MED's P/E(ttm) is ranked lower than
66% of the 670 Companies
in the Global Specialty Retail industry.

( Industry Median: 20.90 vs. MED: 28.38 )
Ranked among companies with meaningful P/E(ttm) only.
MED' s 10-Year P/E(ttm) Range
Min: 8.98  Med: 21.49 Max: 61.03
Current: 28.38
8.98
61.03
Forward P/E 14.88
MED's Forward P/E is ranked lower than
51% of the 379 Companies
in the Global Specialty Retail industry.

( Industry Median: 14.90 vs. MED: 14.88 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 29.50
MED's PE(NRI) is ranked lower than
67% of the 665 Companies
in the Global Specialty Retail industry.

( Industry Median: 20.70 vs. MED: 29.50 )
Ranked among companies with meaningful PE(NRI) only.
MED' s 10-Year PE(NRI) Range
Min: 8.97  Med: 21.77 Max: 61.23
Current: 29.5
8.97
61.23
P/B 3.92
MED's P/B is ranked lower than
78% of the 846 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.69 vs. MED: 3.92 )
Ranked among companies with meaningful P/B only.
MED' s 10-Year P/B Range
Min: 1.36  Med: 3.69 Max: 10.95
Current: 3.92
1.36
10.95
P/S 1.23
MED's P/S is ranked lower than
72% of the 901 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.65 vs. MED: 1.23 )
Ranked among companies with meaningful P/S only.
MED' s 10-Year P/S Range
Min: 0.49  Med: 1.32 Max: 4.81
Current: 1.23
0.49
4.81
PFCF 15.81
MED's PFCF is ranked higher than
58% of the 460 Companies
in the Global Specialty Retail industry.

( Industry Median: 19.54 vs. MED: 15.81 )
Ranked among companies with meaningful PFCF only.
MED' s 10-Year PFCF Range
Min: 8.43  Med: 17.11 Max: 165
Current: 15.81
8.43
165
POCF 12.62
MED's POCF is ranked higher than
50% of the 618 Companies
in the Global Specialty Retail industry.

( Industry Median: 12.72 vs. MED: 12.62 )
Ranked among companies with meaningful POCF only.
MED' s 10-Year POCF Range
Min: 5.47  Med: 12.40 Max: 51.82
Current: 12.62
5.47
51.82
EV-to-EBIT 9.27
MED's EV-to-EBIT is ranked higher than
73% of the 714 Companies
in the Global Specialty Retail industry.

( Industry Median: 14.67 vs. MED: 9.27 )
Ranked among companies with meaningful EV-to-EBIT only.
MED' s 10-Year EV-to-EBIT Range
Min: 4.8  Med: 12.00 Max: 39.4
Current: 9.27
4.8
39.4
PEG 2.52
MED's PEG is ranked lower than
63% of the 309 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.80 vs. MED: 2.52 )
Ranked among companies with meaningful PEG only.
MED' s 10-Year PEG Range
Min: 0.2  Med: 0.77 Max: 4.78
Current: 2.52
0.2
4.78
Shiller P/E 20.59
MED's Shiller P/E is ranked lower than
51% of the 475 Companies
in the Global Specialty Retail industry.

( Industry Median: 20.36 vs. MED: 20.59 )
Ranked among companies with meaningful Shiller P/E only.
MED' s 10-Year Shiller P/E Range
Min: 12.14  Med: 25.60 Max: 96.69
Current: 20.59
12.14
96.69
Current Ratio 3.78
MED's Current Ratio is ranked higher than
91% of the 856 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.57 vs. MED: 3.78 )
Ranked among companies with meaningful Current Ratio only.
MED' s 10-Year Current Ratio Range
Min: 0.99  Med: 3.26 Max: 6.73
Current: 3.78
0.99
6.73
Quick Ratio 3.23
MED's Quick Ratio is ranked higher than
93% of the 856 Companies
in the Global Specialty Retail industry.

( Industry Median: 0.86 vs. MED: 3.23 )
Ranked among companies with meaningful Quick Ratio only.
MED' s 10-Year Quick Ratio Range
Min: 0.46  Med: 2.30 Max: 4.52
Current: 3.23
0.46
4.52
Days Inventory 77.68
MED's Days Inventory is ranked higher than
52% of the 861 Companies
in the Global Specialty Retail industry.

( Industry Median: 81.82 vs. MED: 77.68 )
Ranked among companies with meaningful Days Inventory only.
MED' s 10-Year Days Inventory Range
Min: 79.81  Med: 108.41 Max: 258.67
Current: 77.68
79.81
258.67
Days Sales Outstanding 2.76
MED's Days Sales Outstanding is ranked higher than
83% of the 731 Companies
in the Global Specialty Retail industry.

( Industry Median: 13.01 vs. MED: 2.76 )
Ranked among companies with meaningful Days Sales Outstanding only.
MED' s 10-Year Days Sales Outstanding Range
Min: 0.88  Med: 8.40 Max: 76.69
Current: 2.76
0.88
76.69

Valuation & Return

vs
industry
vs
history
Price/Net Cash 9.49
MED's Price/Net Cash is ranked higher than
59% of the 97 Companies
in the Global Specialty Retail industry.

( Industry Median: 12.24 vs. MED: 9.49 )
Ranked among companies with meaningful Price/Net Cash only.
MED' s 10-Year Price/Net Cash Range
Min: 8.3  Med: 20.25 Max: 382.25
Current: 9.49
8.3
382.25
Price/Net Current Asset Value 5.98
MED's Price/Net Current Asset Value is ranked lower than
58% of the 424 Companies
in the Global Specialty Retail industry.

( Industry Median: 4.54 vs. MED: 5.98 )
Ranked among companies with meaningful Price/Net Current Asset Value only.
MED' s 10-Year Price/Net Current Asset Value Range
Min: 5.25  Med: 11.00 Max: 164.67
Current: 5.98
5.25
164.67
Price/Tangible Book 3.86
MED's Price/Tangible Book is ranked lower than
72% of the 784 Companies
in the Global Specialty Retail industry.

( Industry Median: 2.00 vs. MED: 3.86 )
Ranked among companies with meaningful Price/Tangible Book only.
MED' s 10-Year Price/Tangible Book Range
Min: 1.11  Med: 3.95 Max: 23.94
Current: 3.86
1.11
23.94
Price/Projected FCF 1.00
MED's Price/Projected FCF is ranked higher than
58% of the 505 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.15 vs. MED: 1.00 )
Ranked among companies with meaningful Price/Projected FCF only.
MED' s 10-Year Price/Projected FCF Range
Min: 1.01  Med: 3.20 Max: 11.53
Current: 1
1.01
11.53
Price/DCF (Earnings Based) 1.04
MED's Price/DCF (Earnings Based) is ranked higher than
55% of the 85 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.05 vs. MED: 1.04 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 0.97
MED's Price/Median PS Value is ranked higher than
56% of the 816 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.06 vs. MED: 0.97 )
Ranked among companies with meaningful Price/Median PS Value only.
MED' s 10-Year Price/Median PS Value Range
Min: 0.17  Med: 0.98 Max: 4.61
Current: 0.97
0.17
4.61
Price/Peter Lynch Fair Value 4.01
MED's Price/Peter Lynch Fair Value is ranked lower than
93% of the 189 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.47 vs. MED: 4.01 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
MED' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4  Med: 0.93 Max: 4.7
Current: 4.01
0.4
4.7
Price/Graham Number 1.73
MED's Price/Graham Number is ranked lower than
59% of the 565 Companies
in the Global Specialty Retail industry.

( Industry Median: 1.44 vs. MED: 1.73 )
Ranked among companies with meaningful Price/Graham Number only.
MED' s 10-Year Price/Graham Number Range
Min: 0.2  Med: 1.82 Max: 5.64
Current: 1.73
0.2
5.64
Earnings Yield (Greenblatt) (%) 10.85
MED's Earnings Yield (Greenblatt) (%) is ranked higher than
79% of the 883 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.60 vs. MED: 10.85 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
MED' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: 2.5  Med: 8.35 Max: 20.7
Current: 10.85
2.5
20.7
Forward Rate of Return (Yacktman) (%) 13.38
MED's Forward Rate of Return (Yacktman) (%) is ranked higher than
68% of the 517 Companies
in the Global Specialty Retail industry.

( Industry Median: 5.46 vs. MED: 13.38 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
MED' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -2.9  Med: 30.65 Max: 61.6
Current: 13.38
-2.9
61.6

Analyst Estimate

Dec15 Dec16
Revenue(Mil) 275 278
EPS($) 1.78 1.85
EPS without NRI($) 1.78 1.85

Business Description

Industry: Retail - Apparel & Specialty » Specialty Retail
Compare:TSCO, AMZN, EBAY, FIVE, AZO » details
Traded in other countries:MDF.Germany,
Medifast Inc is a Delaware Corporation, incorporated in 1993. The Company is engaged in the productions, distributions, and sales of weight loss and weight management products and other consumable health and diet products. Its product lines include weight loss and management, meal replacement, and vitamins. Its products and services are sold to weight loss program participants via the Internet, telephone, and brick and mortar clinics. It operates in two reportable segments; Medifast, and MWCC and Wholesale. The Medifast segment consists of the sales from Medifast Direct Marketing and Take Shape For Life. The MWCC and Wholesale segment consists of the sales of Medifast Corporate and Franchise Weight Control Centers as well as Medifast Wholesale Physicians and international sales. Medifast Weight Control Centers is the brick and mortar clinic channel of the Company with affiliate-owned locations in Pennsylvania, New Jersey, Delaware, Texas, Florida, Maryland, North Carolina and Virginia. Medifast Weight Control Centers offer a high-touch model including comprehensive Companys programs for weight loss and maintenance, customized client counseling, an InBody body composition analysis, and monitoring with a BodyGem indirect calorimeter that determines resting metabolic rates. In the direct-to-consumer channel, Medifast Direct, customers order its product directly through the Companys website, www.medifast1.com or its in-house call center. Take Shape For Life is the personal coaching division of the Company. It enriches lives by providing clinically proven weight loss and weight management products and programs. It offers clinically proven products and programs for weight management, weight maintenance, and long-term health through multiple channels of distribution. It offers a variety of weight loss and weight management products under the Medifast and Essential 1 brands and for select private label customers. Its line includes more than 75 options, including, but not limited to bars, bites, pretzels, puffs, cereal crunch, drinks, eggs, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups. The Company continues to build and leverage its core brand through multiple marketing strategies for each of its distinct distribution channels such as Medifast Direct, Medical Wholesale, Medifast Weight Control Centers, and Take Shape For Life to their target audiences. It has also developed a comprehensive social media strategy utilizing Facebook, Twitter, YouTube, blogger endorsements, and more. The Company competes with NutriSystem Inc., Herbalife Ltd., USANA Health Sciences, and Weight Watchers International, Inc. The formulation, processing, packaging, and labeling of the Company's products is subject to regulation by several federal agencies, but principally by the FDA.
» More Articles for MED

Headlines

Articles On GuruFocus.com
Medgold-Centerra Drilling Program Intersects 7.7m @ 4.4 g/t Au from Surface at Lagares Project, Port Jul 27 2015 
Boticas Exploration Update-Medgold Increases Exploration Target at Limarinho Zone Jul 21 2015 
Medgold-Koza Agreement Terminated Jul 20 2015 
Medgold Issues Shares for Services Jul 06 2015 
Medgold-Centerra Drilling Program at Lagares Project, Portugal Intersects 17.5 m of 4.5 g/t Au Jul 02 2015 
NutriSystem Stock Surges On Upbeat Q4 2014 Results Mar 04 2015 
This Company Focuses on Consumer Preferences in the Entire World Dec 17 2014 
Is It Time to Buy Avon? Dec 11 2014 
Medgold Options Portugal Licences to Centerra Gold Dec 09 2014 
Medgold Reports 69 m @ 4.15 g/t Au from Channel Sampling at the Lagares Gold Project, Portugal Dec 02 2014 

More From Other Websites
Take Shape For Life President Appointed as Direct Selling Association Leader Aug 27 2015
Take Shape For Life President Appointed as Direct Selling Association Leader Aug 27 2015
MEDIFAST INC Financials Aug 21 2015
Moving Average Crossover Alert: Medifast (MED) Aug 14 2015
Medifast Honored as 'Company of the Year' by Best in Biz Awards 2015 International Aug 13 2015
Nippon Suisan Kaisha, Ltd. Earnings Q2*, 2015 Aug 13 2015
10-Q for Medifast, Inc. Aug 12 2015
MEDIFAST INC Files SEC form 8-K, Regulation FD Disclosure Aug 12 2015
MEDIFAST INC Files SEC form 10-Q, Quarterly Report Aug 10 2015
Medifast, Inc. to Participate in the Canaccord Genuity 35th Annual Growth Conference Aug 10 2015
Herbalife Ltd. Earnings Analysis: By the Numbers Q2*, 2015 Aug 10 2015
Medifast, Inc. to Participate in the Canaccord Genuity 35th Annual Growth Conference Aug 10 2015
Edited Transcript of MED earnings conference call or presentation 5-Aug-15 8:30pm GMT Aug 06 2015
Medifast hits earnings estimates as execs focus on 'reinvigorating revenue' Aug 05 2015
Medifast posts 2Q profit Aug 05 2015
Medifast posts 2Q profit Aug 05 2015
Medifast, Inc. Announces Second Quarter 2015 Financial Results Aug 05 2015
MEDIFAST INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 05 2015
Medifast, Inc. Announces Second Quarter 2015 Financial Results Aug 05 2015
Q2 2015 Medifast Inc Earnings Release - After Market Close Aug 05 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK